Literature DB >> 33185004

MDM2 regulates RB levels during genotoxic stress.

Jesus Hernandez-Monge1, Mayra Martínez-Sánchez2, Adriana Rousset-Roman2, Ixaura Medina-Medina2, Vanesa Olivares-Illana2.   

Abstract

The retinoblastoma tumour suppressor protein (RB) regulates a number of diverse cellular functions including differentiation, angiogenesis, chromatin remodelling, senescence and apoptosis. The best-characterised function of RB is cell cycle regulation, and it has been considered a phosphoprotein regulated by cyclin-dependent kinases. In its hypophosphorylated form, RB binds the transcription factor E2F1, arresting the cell cycle in the G1 phase. Here, we show that MDM2 controls the cell cycle through synthesis and degradation of RB protein in a cell cycle condition-dependent fashion. MDM2 induces G1 cell cycle arrest by enhancing the translation of the RB mRNA under genotoxic stress. Translation requires direct interaction between the RB mRNA and the MDM2 protein that accompanies the RB mRNA to the polysomes. However, MDM2 ubiquitinates and degrades RB protein at the G2/M phase under genotoxic stress. The ATM phosphomimetic mutant MDM2(S395D) corroborates that the effect on the RB levels is dependent on the DNA damage. These results provide the basis of a dual regulatory mechanism by which MDM2 controls cell cycle progression during DNA damage.
© 2020 The Authors.

Entities:  

Keywords:  MDM2; RB; RB mRNA; cell cycle; protein translation

Mesh:

Substances:

Year:  2020        PMID: 33185004      PMCID: PMC7788445          DOI: 10.15252/embr.202050615

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   9.071


  18 in total

Review 1.  The p53-Mdm2 module and the ubiquitin system.

Authors:  Dan Michael; Moshe Oren
Journal:  Semin Cancer Biol       Date:  2003-02       Impact factor: 15.707

2.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle.

Authors:  D W Goodrich; N P Wang; Y W Qian; E Y Lee; W H Lee
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

3.  The p53 mRNA-Mdm2 interaction.

Authors:  Nadia Naski; Madhavsai Gajjar; Karima Bourougaa; Laurence Malbert-Colas; Robin Fåhraeus; Marco M Candeias
Journal:  Cell Cycle       Date:  2009-01-03       Impact factor: 4.534

Review 4.  RB and cell cycle progression.

Authors:  C Giacinti; A Giordano
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

Review 5.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

6.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

Authors:  R Maya; M Balass; S T Kim; D Shkedy; J F Leal; O Shifman; M Moas; T Buschmann; Z Ronai; Y Shiloh; M B Kastan; E Katzir; M Oren
Journal:  Genes Dev       Date:  2001-05-01       Impact factor: 11.361

7.  Glutamic acid mutagenesis of retinoblastoma protein phosphorylation sites has diverse effects on function.

Authors:  S Barrientes; C Cooke; D W Goodrich
Journal:  Oncogene       Date:  2000-01-27       Impact factor: 9.867

8.  P53 mRNA controls p53 activity by managing Mdm2 functions.

Authors:  Marco M Candeias; Laurence Malbert-Colas; Darren J Powell; Chrysoula Daskalogianni; Magda M Maslon; Nadia Naski; Karima Bourougaa; Fabien Calvo; Robin Fåhraeus
Journal:  Nat Cell Biol       Date:  2008-09       Impact factor: 28.824

9.  Allosteric Interactions by p53 mRNA Govern HDM2 E3 Ubiquitin Ligase Specificity under Different Conditions.

Authors:  Ixaura Medina-Medina; Paola García-Beltrán; Ignacio de la Mora-de la Mora; Jesús Oria-Hernández; Guy Millot; Robin Fahraeus; Horacio Reyes-Vivas; José G Sampedro; Vanesa Olivares-Illana
Journal:  Mol Cell Biol       Date:  2016-07-29       Impact factor: 4.272

10.  Allosteric changes in HDM2 by the ATM phosphomimetic S395D mutation: implications on HDM2 function.

Authors:  Lukas Uhrik; Lixiao Wang; Lucia Haronikova; Ixaura Medina-Medina; Yolanda Rebolloso-Gomez; Sa Chen; Borivoj Vojtesek; Robin Fahraeus; Lenka Hernychova; Vanesa Olivares-Illana
Journal:  Biochem J       Date:  2019-11-15       Impact factor: 3.857

View more
  3 in total

1.  Cryptic in vitro ubiquitin ligase activity of HDMX towards p53 is probably regulated by an induced fit mechanism.

Authors:  Karla Gisel Calderon-González; Ixaura Medina-Medina; Lucia Haronikova; Lenka Hernychova; Ondrej Bonczek; Lukas Uhrik; Vaclav Hrabal; Borivoj Vojtesek; Robin Fahraeus; Jesús Hernández-Monge; Vanesa Olivares-Illana
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

Review 2.  Post-translational modifications on the retinoblastoma protein.

Authors:  Linbin Zhou; Danny Siu-Chun Ng; Jason C Yam; Li Jia Chen; Clement C Tham; Chi Pui Pang; Wai Kit Chu
Journal:  J Biomed Sci       Date:  2022-06-01       Impact factor: 12.771

Review 3.  Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?

Authors:  Lucia Haronikova; Ondrej Bonczek; Pavlina Zatloukalova; Filip Kokas-Zavadil; Martina Kucerikova; Philip J Coates; Robin Fahraeus; Borivoj Vojtesek
Journal:  Cell Mol Biol Lett       Date:  2021-12-15       Impact factor: 5.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.